Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angio Edema Hereditary”

185 trials

Showing 20 of 185 results

Early research (Phase 1)Study completedNCT02663687
What this trial is testing

Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects

Who this might be right for
Hereditary Angioedema (HAE)
Shire 48
Large-scale testing (Phase 3)Study completedNCT02303626
What this trial is testing

12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks

Who this might be right for
Hereditary AngioedemaHAE
BioCryst Pharmaceuticals 110
Not applicableUnknownNCT05776784
What this trial is testing

Status of Dental Care Practices in Patients With Hereditary Angioedema

Who this might be right for
Angio Edema Hereditary
University Hospital, Grenoble 800
Large-scale testing (Phase 3)Ended earlyNCT02670720
What this trial is testing

Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHAE
BioCryst Pharmaceuticals 6
Early research (Phase 1)Study completedNCT03136237
What this trial is testing

A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 54
Large-scale testing (Phase 3)Looking for participantsNCT06679881
What this trial is testing

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Who this might be right for
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V. 130
Large-scale testing (Phase 3)Enrolling By InvitationNCT04933721
What this trial is testing

Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies

Who this might be right for
Hereditary AngioedemaHAE
BioCryst Pharmaceuticals 139
Not applicableAvailableNCT07159464
What this trial is testing

Post Study Access of CSL312 (Garadacimab) for Pediatric Participants With Hereditary Angioedema Who Have Completed the CSL312_3003 Study

Who this might be right for
Hereditary Angioedema (HAE)
CSL Behring
Not applicableStudy completedNCT05509569
What this trial is testing

A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 32
Large-scale testing (Phase 3)Study completedNCT00748202
What this trial is testing

Berinert P Study of Subcutaneous Versus Intravenous Administration

Who this might be right for
Hereditary Angioedema
Johann Wolfgang Goethe University Hospital 24
Not applicableEnded earlyNCT02854397
What this trial is testing

Determination of Specific Biomarkers of Acute Attack of Angioedema Within Pediatric Population

Who this might be right for
Hereditary AngioedemaHealthy Volunteers
University Hospital, Grenoble 31
Not applicableLooking for participantsNCT06806618
What this trial is testing

HAE Burden and Crisis Management

Who this might be right for
Hereditary Angioedema (HAE)
University Hospital, Grenoble 300
Early research (Phase 1)Study completedNCT03202784
What this trial is testing

A Relative Bioavailability Study of Two Formulations of BCX7353

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT00125151
What this trial is testing

C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema

Who this might be right for
Angioedema
Prothya Biosolutions 15
Testing effectiveness (Phase 2)Ended earlyNCT05055258
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II

Who this might be right for
Angioedema, Hereditary, Types I and II
KalVista Pharmaceuticals, Ltd. 33
Testing effectiveness (Phase 2)Study completedNCT05695248
What this trial is testing

STAR-0215 in Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Astria Therapeutics, Inc. 29
Post-approval studies (Phase 4)Study completedNCT07290855
What this trial is testing

Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedema

Who this might be right for
Bradykinin-mediated AngioedemaHereditary Angioedema (HAE)
Nang Kuang Pharmaceutical Co., Ltd. 5
Large-scale testing (Phase 3)Study completedNCT00262080
What this trial is testing

Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 91
Not applicableStudy completedNCT05489640
What this trial is testing

A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 85
Not applicableApproved For MarketingNCT06628713
What this trial is testing

Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd.
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation